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Iinical

genal Involvement in Type 2 Diabetes Mellitus: A Clinicopathologic
Study of the Henry Ford Hospital Experience
Francis Dumler, MD,* Vijay Kumar, MD,^ Raymond N. Romanski, MD,^
Pedro Cortes, MD,* and Nathan W. Levin, MD*

To better understand renal dysfunction in type 2 diabetes mellitus, we studied the clinical and autopsy
findings in comparable cohorts of 108 diabetic and 77 nondiabetic patients. In the diabetic group, no
differences were noted between black and white patients in blood glucose concentrations, mean blood
pressure, or the prevalence of diabetic glomerulosclerosis. However, the prevalence of renal
insufficiency was significantly greater (P = 0.002) in black diabetics (58%) than in white diabetics
(35%). black controls (28%), and white controls (20%). Logistic regression analysis demonstrated a
significant association of renal insufficiency with diabetes (P = 0.006) and race (P = 0.032). butnot
with mean blood pressure, age, or sex. An additional nonspecific glomerular lesion commonly found
was global sclerosis. The occurrence of this lesion was significantly greater (P = O.OOI) in black
diabetics (42% ± 5%) than in white diabetics (26% ± 5%), black controls (19% ± 4%), and white
controls (21% ± 4%), and was highly correlated (P = O.OOI) to serum creatinine concentrations. In
patients with serum creatinine concentrations lower than 1.6 mg/dL, kidney weight was significantly
greater (P = 0.03) in diabetics with diabetic glomerulosclerosis (405 ± 32 g) as compared to those
without it (300 ± 25 g) or to control patients (329 ± 13 g). This study demonstrates that the overall
prevalence of diabetic glomerulosclerosis in this group of type 2 diabetics is 45%, and that renal
enlargement is present in these patients prior to the development of significant renal insufficiency. In
addition, renal insufficiency and end-stage renal failure are more common in black than in white
diabetics. (Henry FordHosp MedJ 1987:35:221-5)

enal disease in type 1 (insulin-dependent) diabetes mellitus
is well characterized and has been the subject of intense
study (1-9). That clinical renal disease may differ in type 1 and
type 2 (noninsulin-dependent) diabetes is suggested by a tenfold
difference in the prevalence of diabetic renal disease as the cause
of death in patients younger (20%) and older (2%) than 40 years
of age. Although abnormal proteinuria may occur in 50% of patients with type 2 diabetes, the glomemlarfiltrationrate does not
decrease progressively in most of these patients (10). While the
vast majority of patients with type I diabetes mellitus who
develop renal insufficiency have diabetic nephropathy (8), the
extent to which diabetic nephropathy is responsible for renal insufficiency in type 2 diabetics is not well defined. Because the
relationship between renal insufficiency and diabetic nephropathy requires histological confirmation, a retrospective autopsy
study of 108 consecutive cases of type 2 diabetes mellitus was
undertaken to address this issue. In addition, comparisons were
made between blacks and whites in view of apparent racial differences in the prevalence of end-stage renal failure from various causes (11).

R

Methods
Patient population
The Medical Records Department at Henry Ford Hospital
identified in its computerized index 650 patients who were older
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than age 50 at death and whose complete medical and autopsy
records were available for study. Of these 650 patients, 145 had
been classified by their primary physician as having diabetes
mellitus. The diagnosis of type 2 diabetes was retrospectively
confirmed, and patients were included in the study oitiy if the
following criteria were documented: 1) a negative history of diabetic ketoacidosis; 2) age at onset of diabetes of 40 years or
older; and 3) body weight not less than 95% of the calculated
ideal body weight based on sex, age, and height. A total of 108
patients with type 2 diabetes as defined by these criteria were
entered in the study. The remaining 505 nondiabetic patients
were entered into the control group only if 1) plasma glucose
concentrations were consistently lower than 180 mg/dL regardless of time or circumstances, and 2) body weight was at
least 95% of the calculated ideal body weight. A total of 77 patients fulfilled these criteria.
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Table 1
Clinical Characteristics ofthe Patient Population Studied
CONTROLS

DIABETICS
Number of patients
Age (years)
Males (%)
Body weight (kg)
Mean blood pressure
(mm Hg)
Semm creatinine
(mg/dL)
Duration of diabetes
(years)
Patients on insulin (%)

59
68 ± 2
56
72 ± 3

Black
37
62 ± 2*
51
72 ± 3

White
40
69 ± 2
40
76 ± 2

107 ± 2t

106 ± 2t

98 ± 4

101 ± 2

5.5 ± 0.8t

3.0 ± 0.05

3.3 ± 0. i

2.1 ± 0.6

14 ± 1
44

13 ± 1
55

—
—

—
—

Black
49
67 ± 2
69
71+4

White

*P = 0.03 when compared to the other groups.
tP = 0.02 when compared to controls.
tP = 0.02 when compared to the other groups.

Clinicopathologic evaluation
The following information was recorded for each patient:
duration of diabetes, mode of diabetes therapy, mean blood
pressure, blood glucose, degree of proteinuria, and semm creatinine concentrations at diagnosis and during the last admission.
Blood pressure and blood glucose measurements during the last
hospital admission were reviewed, and mean values utilized for
analysis. Renal insufficiency was arbitrarily defined as a semm
creatinine concentration consistently greater than 2 mg/dL, and
end-stage renal failure as a seram creatinine concentration consistentiy greater than 8 mg/dL or by the use of maintenance dialysis procedures. To ensure that renal function was documented
during a representative steady state, if sudden changes in renal
function occurred, the stable serum creatinine concentration
preceding the acute event was used for analysis. Cardiac weight
and left ventricular thickness measurements were recorded.
All renal histological material was analyzed in a blind manner by an independent observer who had no knowledge of the
clinical or autopsy findings. Autopsy material for light microscopic studies was considered adequate for reexamination in 134
patients because postmortem alterations did not interfere with
the evaluation of the following: 1) presence and degree of global
glomerular sclerosis, 2) presence and degree of hyaline arteriosclerosis and intimal thickness of interlobular and arcuate
arteries, and 3) presence of diabetic glomerulosclerosis. All
glomemli in each kidney section were examined while avoiding
areas of infarction. Global glomeralar sclerosis was defined as
a rounded, solid scar replacing the entire glomerular tuft.
Bowman's space, and blending with or obscuring Bowman's
capsule. The degree of diabetic glomeralosclerosis and of arteriosclerosis was graded by using a 0 to 4 -F scale at the end of
each slide examination. Diabetic glomerulosclerosis lesions
were further classified as diffuse or nodular.
Data management and statistical analysis
Identification of all patients eligible for the study was conducted by the Medical Records Department without prior
knowledge of the presence or absence of diabetes. All statistical
analyses were carried out with the Statistical Analysis System
(12). Results are expressed as mean ± SEM or in frequency distributions. Comparison of means was carried out by analysis of
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variance followed by Duncan's multiple-range test. Frequency
distributions were compared by analysis. The effects of risk
factors for the development of renal insufficiency were analyzed
by logistic regression.

Results
The characteristics of the patient populations are shown in
Table 1. No differences were noted in age, duration of diabetes,
or in the prevalence of insulin therapy between black and white
diabetics (Table 1). There were no differences in sex distribution
or body weight between groups. Body mass index was also similar in all groups (39 ± 1, 39 ± 1, 39 ± 1, and 40 ± 1 kg/m^ in
black diabetic, white diabetic, black control, and white control
patients, respectively). Black control patients had a lower mean
age (P = 0.03) than the other groups. Mean blood pressures
were significantly higher (P = 0.02) in diabetic than in control patients, but blood pressure differences were not observed
between races in diabetic or control patients (Table 1). No differences in cardiac weights were noted between groups: black
diabetics (485 ± 30 g), white diabetics (488 ± 11 g), black controls (508 ± 24 g), and white controls (498 ± 22 g). Left ventricular thickness was greater (P = 0.005) in white controls
(1.69 ± 0.06 cm) than in black controls (1.59 ± 0.06 cm),
white diabetics (1.41 ± 0.09 cm), or black diabetics (1.43 ±
0. 10 cm).
Routine urinalysis was negative for protein in 47% of control
and 16% of diabetic patients (P = 0.001). A qualitative urinary
protein excretion greater than 300 mg/dL was found in three
(4%) control patients and in ten (3%) diabetic patients without
diabetic nephropathy. Seram creatinine concentrations were significantiy higher (P = 0.02) in black diabetic patients than in
white diabetic or control patients (Table 1). The prevalence of
renal insufficiency was significantly greater (P = 0.002) i "
black diabetics (58%) as compared to white diabetics (35%)'
black controls (28%), or white controls (20%), as shown in
1. Similarly, the prevalence of end-stage renal disease was stg'
nificantiy greater (P = 0.05) in black diabetics (27%) than i"
white diabetics (10%), black controls (14%), and white controls
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Table 2
Prevalence (%) of Histological Diabetic Renal Disease

Number of patients
Diabetic glomeralosclerosis
Grade 3 to 4 -1- arteriosclerosis
Percent of glomemli with
global sclerosis

DIABETICS
Black
White
29
35
45
40
38
24
42 ± 5*

26 ± 5

CONTROLS
Black
White
40
30

—

—

19 ± 4

21 ± 4

12

19

*P = 0.001 when compared to the other groups.

t. Frequency
ffects of risk
ere analyzed

ire shown in
I of diabetes,
ck and white
t distribution
ras also sim± Ikg/m^n
A'hite control
i lower mean
od pressures
than in connot observed
le 1). No dif;roups: black
l), black cong). Left venhite controls
± 0.06 cm),
;tics (1.43 ±
7% of control
tative urinary
)und in three
:ients without
ions were sigtients than in
prevalence of
= 0.002) in
series (35%).
shown in Fig
lease was sig27%) than in
A-hite controls
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%) (Fig 1). Only a weak correlation was found between mean
blood pressure and serum creatinine concentrations in black
(R = 0.246) and white (R = 0.132) patients.
The prevalence of diabetic glomeralosclerosis was similar in
black and white diabetic patients (Table 2), and the prevalence of
renal insufficiency was 66% in patients with diabetic
glomeralosclerosis and 36% in patients without it (x^ = 4.95;
p = NS). No differences were noted in blood glucose concentrations between black (277 ± 22 mg/dL) and white (269 ±
20 mg/dL) diabetic patients or between patients with and without diabetic glomeralosclerosis (265 ± 25 mg/dL and 282 ±
18 mg/dL, respectively).
Grade 3 and 4 -F diabetic glomeralosclerosis were similarly
present in black and white diabetics. Although the prevalence of
grade 3 to 4 -I- lobular and arcuate arteriosclerosis was greater in
black diabetics than in any other group, the differences were not
statistically significant. However, the occurrence of global
glomerular sclerosis was significantly greater (P = 0.001) in
black diabetics than in white diabetics, black controls, or white
controls (Table 2). A significant correlation was found between
the degree of global sclerosis and the logarithm of serum
creatinine concentrations in all patient groups (R = 0.729; P =
0.001).
No differences in kidney weights between groups were noted:
black diabetics (271 ± 17 g), white diabetics (313 ± 18 g), black
controls (303 ± 19 g), and white controls (291 ± 15 g). However, when control and diabetic patients with and without
diabetic nephropathy were grouped according to their serum
creatinine concentrations, a significant increase in kidney
weight (P = 0.03) was demonstrated at seram creatinine concentrations between 0.5 to 1.5 mg/dL in diabetics with diabetic
nephropathy (405 ± 32 g) when compared to those without it
(300 ± 25 g) or to control patients (329 ± 13 g) (Fig 2). In
patients with seram creatinine concentrations greater than 1.6
tng/dL, this difference was not apparent (Fig 2).
The effects of diabetes, race, mean blood pressure, age, and
sex in the development of renal insufficiency (including endstage renal failure) were assessed by logistic regression. The
logistic regression model demonstrated significant effects only
for diagnosis (diabetic or control) and race (Table 3). The relative risk for developing renal insufficiency was increased 36
'unes if diabetes was present and was fourfold greater in black
patients. The other variables studied (mean blood pressure, age,
^d sex) resulted in no added risk.
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Renal Insufficiency
End Stage Renal Disease
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CW

Patient Group by Diagnosis and Race

Fig I—Prevalence of renal insufficiency (defined as a serum
creatinine concentration > 2.0 mg/dL) and of end-stage renal
disease (defined as a serum creatinine > 8.0 mg/dL or need for
chronic dialysis) in control and type 2 diabetic patients grouped
by race. (DB = diabetic, black; DW = diabetic, white; CB =
control, black; CW = control, white.) (P = 0.002 for renal
insufficiency, and P < 0.05 for end-stage renal disease.)

•
^
•

Diabetic («)
Diabetic I-)
Contral

S.Cr. Range

Fig 2—Kidney weight in grams in control and diabetic patients
with (-\-) and without ( —) histological evidence of diabetic
nephropathy when grouped according to serum creatinine concentrations (*P = 0.03 when compared to the other groups).
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Table 3
Logistic Regression Analysis Data
Variable
Diagnosis
Race
Mean blood pressure
Age
Sex

Beta*
1.028
0.772
0.016
-0.03
-0.19

P Value
0.0065
0.0317
0.1646
0.0918
0.6048

*The estimated regression coefficient for each variable in the model (maximum likelihood estimates).

Discussion
The puipose of this study was to determine 1) the relationship
between the presence of diabetic nephropathy and renal insufficiency, and 2) whether the prevalence of renal insufficiency is
different in black and white type 2 diabetic patients. A longitudinal prospective study would be ideal in providing data on
renal function, blood pressure, and blood glucose control, but
would require a long follow-up period. A cross-sectional design
could provide adequate data on the prevalence of renal insufficiency in the study population. However, histological confirmation of diabetic nephropathy would require a substantial number
of kidney biopsies, even in patients without apparent renal disease, which poses a serious ethical problem. For these reasons,
a retrospective cross-sectional autopsy study was chosen.
As in type 1 diabetes (13), an increase in renal size occurred in
type 2 diabetic patients with diabetic nephropathy while renal
function was preserved (Fig 2). The prevalence of histologically
documented diabetic glomeralosclerosis was 45%, which correlates to previously reported prevalences of 25% to 60% (14-18).
In addition, the 36% prevalence of renal insufficiency in diabetic patients without nephropathy indicates that a significant
number of patients with type 2 diabetes mellitus have renal dysfunction not related to diabetic renal disease. Hypertensive and
atherosclerotic renal disease accounted for the majority of renal
dysfunction in patients without diabetic glomerulosclerosis.
While the prevalence of renal insufficiency and end-stage renal
failure (35% and 10%, respectively) in the white population is
simUar to that in other studies on type 2 diabetes (4,8,14,19-21),
renal insufficiency and end-stage renal failure were significantly
more frequent in black than in matched white diabetics (Fig 1)
and approached that seen in type 1 diabetes (8). Observations
from the Michigan Kidney Registry also indicate a fourfold increase in the occurrence of end-stage renal failure in black diabetics over age 40 when compared to white diabetics, with no
differences in younger age groups (21). The prevalence of renal
insufficiency in this study is a minimum estimate, since renal
insufficiency was arbitrarily defined as a seram creatinine concentration greater than 2 mg/dL to ensure that all patients included in this category had reduced renal function.
Age, insulin requirement, and duration of diabetes (Table I)
do not account for the differences between black and white
diabetics; however, this study cannot appropriately evaluate
the possible relevance of the degree of diabetic control (22).
Nevertheless, mean glucose concentrations during the last hospitalization did not differ between black and white diabetic
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patients or between diabetic patients with and without renal
insufficiency.
The possible role of hypertension in the progression of renal
insufficiency in diabetes has attracted much attention
(5,6,23-26). In this study, logistic regression analysis didnot
demonstrate an effect of mean blood pressure, age, or sex on the
prevalence of renal insufficiency. Although mean blood pressure
was greater in diabetic patients, only race and the presence or
absence of diabetes were associated with a significant increased
risk for renal insufficiency. Several possibilities may account for
the absence of a blood pressure effect on renal function in this
study. The severity of hypertension throughout the overal] duration of diabetes might not have been adequately represented by
blood pressure measurements during the last hospital admission. However, cardiac weights were similar, and no differences
were noted in left ventricular thickness between black and white
diabetics. Patient selection is another important possibility.
However, diabetic patients were drawn from an autopsy population that included all patients identified as diabetic independent
of race. In addition, the distribution by race in the population
studied is similar to the race distribution in Detroit. Finally,
blacks may have an intrinsic predisposition for developing more
severe glomerulosclerosis than whites at any given degree of
hypertension. This difference could be further enhanced by the
presence of diabetic microvascular disease. The combination of
diabetes and race would then be a much stronger predictor of
renal insufficiency than blood pressure alone, as demonstrated
in this study. Indeed, black hypertensive patients have more severe nephrosclerosis and a lower renal blood flow than whites
matched for age and degree of hypertension (27,28). In keeping
with this, black diabetic patients had significantiy more global
sclerosis than white diabetic or control patients (Table 2), and a
significant correlation was found between the degree of global
sclerosis and seram creatinine concentrations. Global sclerosis
is also commonly observed in patients with focal glomeralar
sclerosis (29), which is the most characteristic lesion observed
in heroin nephropathy (30). With equal exposure to nephrotoxic
factors, the prevalence of end-stage renal failure is also significantly greater in black than in white heroin abusers (31).
A racially determined response pattern of the renal microvasculature to various factors which include diabetes and hypertension may result in more severe global sclerosis and greater
loss of renal function in black patients with diabetes mellitus independent of the prevalence of diabetic nephropathy. Further
prospective studies are required to better define the effects of
adequate control of diabetes and hypertension on diabeticinduced renal disease in black and white patients. The implication that end-stage renal failure occurs more frequentiy in
black type 2 diabetic may be relevant in the planning of endstage renal failure treatment programs.

References
1. Brown D M , Andres GA, Hostetter T H , Mauer SM, Price R.
Venkatachalam MA. Kidney complications. Diabetes 1982;3I(suppl l);71-812. Kussman MJ, Goldstein HH, Gleason RE. The clinical course of diabetic
nephropathy. JAMA 1976;236:1861-3.
3. Mauer SM, Steffes MW, Goetz FC, Sutherland DER, Brown DM- D'^'

Renal Involvement in Type 2 Diabetes—Dumler et"

renal

f

betic nephropathy: A perspective. Diabetes 1983;32(suppl 2):52-5.
4. Moloney A, Tunbridge WMG, Ireland JT, Watkins PJ. Mortality from diabetic nephropathy in the United Kingdom. Diabetologia 1983;25:26-30.
5. Mogensen CE. Diabetes mellitus and the kidney. Kidney Int 1982;
21:673-5.
6 Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal
disease with emphasis on the stage of incipient diabetic nephropathy. Diabetes
j983;32(suppl 2):64-78.
7. Krolewski AS, Warram JH, Christlieb AR, Busick EF, Kahn CR. The
changing natural history of nephropathy in type 1 diabetes. Am J Med
1985;78:785-94.
8. Balodimos MC. Diabetic nephropathy In: Marble A, White P, Bradley RF,
Krall LP, eds. Joslin's diabetes mellitus. llth ed. Philadelphia: Lea & Febiger,
1971:526-61.
9. Takazakura E, Nakamoto Y, Hayakawa H, et al. Onset and progression of
diabetic glomemlosclerosis: A prospective study based on serial renal biopsies.
Diabetes 1975;24:1-9.
10. Fabre J, Balant LP, Dayer PG, Fox HM, Vemet AT. The kidney in maturity onset diabetes mellitus: A clinical study of 510 patients. Kidney Int
1982;21:730-8.
11. Rostand SG, Kirk KA, Rutsky EA, Pate BA. Racial differences in the
incidence of treatment for end-stage renal disease. N Engl J Med 1982; 306:
1276-9.
12. SAS user's guide: Statistics. Cary, NC: Statistical Analysis System Publishing Institute, 1982.
13. Mogensen CE, Andersen MJF. Increased kidney size and glomeralar filtration rate in untreated juvenile diabetes: Normalization by insulin-treatment.
Diabetologia 1975;11:221-4.
14. Bell ET. Renal vascular disease in diabetes mellitus. Diabetes 1953;
2:376-89.
15. Lambie AT, MacFarlane A. A clinico-pathological study of diabetic
glomemlosclerosis. Quart J Med 1955;24:125-46.
16. Heptinstall RH. Frequency of diabetic glomemlosclerosis and relation to
sex, age, duration, and severity of diabetes. In: Pathology of the kidney. 2nd ed.
Boston: Little, Brown and Co, 1974.
17. Bennett PH, Burch TA, Miller M. Diabetes mellitus in American (Pima)

Henry Ford Hosp Med J—Vol 35, No 4, 1987

Indians. Lancet I97I;2(July 17): 125-8.
18. Kamenetzky SA, Bennett PH, Dippe SE, Miller M, LeCompte PM.
A clinical and histologic study of diabetic nephropathy in the Pima Indians.
Diabetes 1974;23:61-8.
19. Thomsen AC. The kidney in diabetes mellitus: A clinical and histological
investigation based on renal biopsy material. Copenhagen: Munksgaard, 1965.
20. Sasaki A, Uehara M, Horiuchi N, Hasagawa K. A long-term follow-up
study of Japanese diabetic patients: Mortality and causes of death. Diabetologia
1983;25:309-12.
21. Weiler JM, Wu SCH, Ferguson CW, Hawthorne VM. End-stage renal
disease in Michigan: Incidence, underlying causes, prevalence, and modalities
of treatment. Am J Nephrol 1985;5:84-95.
22. Raskin R PieUi AO, Under R, Shannon WA Jr. The effect of diabetic control on the width of skeletal-muscle capillary basement membrane in patients
with type I diabetes mellitus. N Engl J Med 1983;309:1546-50.
23. Mogensen CE. Long-term antihypertensive treatment (over six years)
inhibiting the progression of diabetic nephropathy. Acta Endocrinol (Copenh)
198l;97(suppl242):31-2.
24. Parving H-H, Andersen AR, Smidt UM, Svendsen PA. Early aggressive
antihypertensive treatment reduces rate of decline in kidney function in diabetic
nephropathy. Lancet 1983;l(May 28):1175-8.
25. Parving H-H, Andersen AR, Smidt UM, OxenboU B, Edsberg B,
Christiansen JS. Diabetic nephropathy and arterial hypertension. Diabetologia 1983;24:10-2.
26. Dmry PL. Diabetes and arterial hypertension. Diabetologia 1983;24:1-9.
27. Levy SB, Talner LB, Coel MN, Holle R, Stone RA. Renal vasculature in
essential hypertension: Racial differences. Ann Intem Med 1978;88:12-6.
28. Frohlich ED, Messerii FH, Dunn FG, Oigman W, Ventura HO. Greater
renal vasoconstriction in black patients with essential hypertension (abstract).
Kidney Int 1983;23:169.
29. Velosa JA, Donadio JV Jr, Holley KE. Focal sclerosing glomerulonephropathy: A clinicopathologic study. Mayo Clin Proc 1975;50:121-33.
30. Rao TKS, Nicastri AD, Friedman EA. Natural history of heroin-associated nephropathy. N Engl J Med 1974;290:19-23.
31. Cunningham EE, Zielezny M A , Venuto RC. Heroin-associated
nephropathy: A nationwide problem. JAMA 1983;250:2935-6.

Renal Involvement in Type 2 Diabetes—Dumler et al 225

